BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2407838)

  • 1. Humoral autoimmunity in systemic rheumatic disease. A review.
    Bernstein RM
    J R Coll Physicians Lond; 1990 Jan; 24(1):18-25. PubMed ID: 2407838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
    Breda L; Nozzi M; De Sanctis S; Chiarelli F
    Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
    Muro Y; Sugiura K; Morita Y; Tomita Y
    Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody testing: procedures and significance in systemic rheumatic diseases.
    Fritzler MJ
    Methods Achiev Exp Pathol; 1986; 12():224-60. PubMed ID: 3083214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annals of the Rheumatic Diseases collection on autoantibodies in the rheumatic diseases: new insights into pathogenesis and the development of novel biomarkers.
    Pisetsky DS
    Ann Rheum Dis; 2023 Oct; 82(10):1243-1247. PubMed ID: 37580110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
    Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
    Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How can the autoantibody detection help in the diagnostics and evaluation of autoimmune rheumatic diseases?].
    Vencovský J
    Vnitr Lek; 2006; 52(7-8):697-701. PubMed ID: 16967611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases.
    Utiyama SR; Zenatti KB; Nóbrega HA; Soares JZ; Skare TL; Matsubara C; Muzzilo DA; Nisihara RM
    Immunol Invest; 2016 Aug; 45(6):566-73. PubMed ID: 27409579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity and origin of rheumatologic autoantibodies.
    Fritzler MJ; Salazar M
    Clin Microbiol Rev; 1991 Jul; 4(3):256-69. PubMed ID: 1889043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological markers in inflammatory rheumatic diseases.
    Hilliquin P
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):993-1006. PubMed ID: 8747080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging technologies in autoantibody testing for rheumatic diseases.
    Olsen NJ; Choi MY; Fritzler MJ
    Arthritis Res Ther; 2017 Jul; 19(1):172. PubMed ID: 28738887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of circulating anticellular antibodies by indirect immunofluorescence on HEp-2 cell substrates: study of the clinical value of rare fluorescence patterns].
    Haberhauer G; Bröll H
    Z Gesamte Inn Med; 1988 Jul; 43(14):377-80. PubMed ID: 3064447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z; Ren Y; Liu D; Lin F; Liang Y
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies associated with rheumatic diseases.
    Griesmacher A; Peichl P
    Clin Chem Lab Med; 2001 Mar; 39(3):189-208. PubMed ID: 11350015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of production and pathogenesis of autoantibodies].
    Mimori T
    Rinsho Shinkeigaku; 2007 Nov; 47(11):855-7. PubMed ID: 18210817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile.
    Meilof JF; Frohn-Mulder IM; Stewart PA; Szatmari A; Hess J; Veldhoven CH; Smeenk RJ; Swaak AJ
    Lupus; 1993 Aug; 2(4):239-46. PubMed ID: 7505695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.